Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Hogan

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Frontiers in Nephrology|July 17, 2024
Examining the role of patient-reported external factors and risk of relapse in anti-neutrophilic cytoplasmic autoantibody vasculitisMary M Collie, Dhruti P Chen, Yichun Hu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 20, 2024
Glucocorticoid Exposure and Infection in Children and Adults With Glomerular Disease: Findings From the Cure Glomerulonephropathy StudyDorey A Glenn, Calvin Andrews, Qian Liu, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated VasculitisBritta E Jones, Jiajin Yang, Akhil Muthigi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2011
Venous thromboembolism in patients with membranous nephropathySophia Lionaki, Vimal K Derebail, Susan L Hogan, et al.
Clinical & Translational Immunology|November 16, 2022
The frequency of Treg subsets distinguishes disease activity in ANCA vasculitisChristian Agosto-Burgos, Eveline Y Wu, Marie A Iannone, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2018
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritisMaria Weiner, Rune Bjørneklett, Zdenka Hrušková, et al.
Kidney International|March 1, 2016
Patients with primary membranous nephropathy are at high risk of cardiovascular eventsTaewoo Lee, Vimal K Derebail, Abhijit V Kshirsagar, et al.
Clinical Transplantation|January 29, 2021
Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantationDhruti P Chen, Ziad S Zaky, Jesse D Schold, et al.
Annals of the Rheumatic Diseases|May 3, 2015
Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitisDonna O Bunch, Carmen E Mendoza, Lydia T Aybar, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2011
Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritisAleeza J Roth, Michael C Brown, Rex Neal Smith, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Nephrology|July 17, 2024
Examining the role of patient-reported external factors and risk of relapse in anti-neutrophilic cytoplasmic autoantibody vasculitisMary M Collie, Dhruti P Chen, Yichun Hu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 20, 2024
Glucocorticoid Exposure and Infection in Children and Adults With Glomerular Disease: Findings From the Cure Glomerulonephropathy StudyDorey A Glenn, Calvin Andrews, Qian Liu, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated VasculitisBritta E Jones, Jiajin Yang, Akhil Muthigi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2011
Venous thromboembolism in patients with membranous nephropathySophia Lionaki, Vimal K Derebail, Susan L Hogan, et al.
Clinical & Translational Immunology|November 16, 2022
The frequency of Treg subsets distinguishes disease activity in ANCA vasculitisChristian Agosto-Burgos, Eveline Y Wu, Marie A Iannone, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2018
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritisMaria Weiner, Rune Bjørneklett, Zdenka Hrušková, et al.
Kidney International|March 1, 2016
Patients with primary membranous nephropathy are at high risk of cardiovascular eventsTaewoo Lee, Vimal K Derebail, Abhijit V Kshirsagar, et al.
Clinical Transplantation|January 29, 2021
Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantationDhruti P Chen, Ziad S Zaky, Jesse D Schold, et al.
Annals of the Rheumatic Diseases|May 3, 2015
Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitisDonna O Bunch, Carmen E Mendoza, Lydia T Aybar, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2011
Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritisAleeza J Roth, Michael C Brown, Rex Neal Smith, et al.
Pageof 14